Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,0.61 [0.43-0.89],0.00918092327878521,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Wald ratio,1,0.51 [0.3-0.85],0.00957692002052091,cis
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,0.68 [0.5-0.92],0.0126813644484552,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,2,1.15 [1.03-1.28],0.0136033407081264,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.68 [0.5-0.93],0.0149088867380405,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,2,0.48 [0.25-0.91],0.0236519431507016,cis
FGF21,Fibroblast growth factor 21,Chapter II Neoplasms,CD2_BENIGN_COLORECANI,Inverse variance weighted,2,1.25 [1.02-1.54],0.0350658644208405,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,2,1.11 [1-1.23],0.0495924882896048,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1.13 [1-1.27],0.0504782645239238,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,2,1.28 [1-1.65],0.054230201637158,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,2,1.8 [0.97-3.34],0.0615078397909398,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Wald ratio,1,0.7 [0.48-1.02],0.0631717487006825,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.67 [0.44-1.03],0.0667846592801469,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,2,1.13 [0.99-1.3],0.0780601791233574,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,2,1.21 [0.98-1.49],0.0781402304188918,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_PULMEMB,Inverse variance weighted,2,1.22 [0.97-1.52],0.0827122332774022,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,2,0.57 [0.29-1.11],0.100563891307999,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,2,1.17 [0.96-1.42],0.117297978731883,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Wald ratio,1,0.35 [0.09-1.31],0.117955187052954,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,2,1.08 [0.98-1.19],0.121939964309226,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,2,0.71 [0.45-1.11],0.133564881686396,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,2,1.45 [0.88-2.38],0.142055509280125,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,2,0.9 [0.78-1.04],0.157385457778357,cis
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.74 [0.49-1.13],0.161519041747891,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_ALCOHOLAC,Inverse variance weighted,2,1.22 [0.91-1.63],0.189304178580407,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,2,0.76 [0.5-1.16],0.201579008946297,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,2,0.67 [0.34-1.3],0.234790326721958,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,2,1.26 [0.86-1.84],0.2376741641066,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.86 [0.67-1.11],0.24598627694718,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,2,0.94 [0.85-1.05],0.265730299518191,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,2,0.94 [0.83-1.05],0.270482550625118,cis
FGF21,Fibroblast growth factor 21,Chapter II Neoplasms,LUNG_CANCER_MESOT,Wald ratio,1,0.61 [0.25-1.48],0.271148592377452,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,2,0.87 [0.68-1.11],0.274002462423028,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,2,0.9 [0.74-1.09],0.276971393510088,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,2,1.15 [0.9-1.47],0.277073366239478,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,2,1.15 [0.89-1.5],0.293815363252639,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,2,0.86 [0.64-1.14],0.294504268369841,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,2,0.93 [0.82-1.07],0.307980954087283,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Wald ratio,1,0.89 [0.71-1.12],0.314951955236676,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Wald ratio,1,1.55 [0.66-3.66],0.316809581465955,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,2,1.22 [0.79-1.9],0.364226920006445,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,2,1.15 [0.85-1.55],0.364792541296199,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,2,1.08 [0.91-1.28],0.369290373759889,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Wald ratio,1,0.74 [0.38-1.44],0.373253888387584,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,0.81 [0.51-1.29],0.376251321560738,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_ACUTPANC,Inverse variance weighted,2,0.89 [0.68-1.16],0.378673016381816,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,0.82 [0.51-1.3],0.390297655547582,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,2,1.18 [0.79-1.76],0.4169080406062,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,2,1.11 [0.85-1.44],0.446414996612359,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,2,0.84 [0.53-1.32],0.446600827174993,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_CHRONPANC,Inverse variance weighted,2,0.76 [0.37-1.57],0.459449159360303,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,2,0.8 [0.43-1.46],0.459629355673849,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_B_DEF,Inverse variance weighted,2,0.73 [0.31-1.72],0.466490425578005,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Wald ratio,1,0.66 [0.21-2.03],0.469591061539219,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_PAD,Wald ratio,1,0.75 [0.34-1.65],0.47600723260861,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,2,1.31 [0.62-2.75],0.478312463236052,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,0.94 [0.8-1.12],0.49202676695607,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Wald ratio,1,0.85 [0.53-1.36],0.498113066765269,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,2,1.05 [0.9-1.22],0.533052712169237,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,2,0.92 [0.7-1.2],0.540693699472293,cis
FGF21,Fibroblast growth factor 21,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,2,1.43 [0.45-4.56],0.543003569878577,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,2,1.04 [0.92-1.16],0.546180784217697,cis
FGF21,Fibroblast growth factor 21,Chapter VI Diseases of the nervous system,G6_NEURO,Wald ratio,1,0.92 [0.71-1.2],0.560459697640672,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Wald ratio,1,0.87 [0.53-1.41],0.563430560389541,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,2,1.13 [0.74-1.73],0.567268706948697,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,2,0.69 [0.19-2.53],0.570564482732568,cis
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,2,1.26 [0.53-3.02],0.599548003746078,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,0.88 [0.54-1.44],0.612948386514967,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,2,1.05 [0.86-1.28],0.619318811410102,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,2,0.85 [0.43-1.64],0.620778857692713,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Wald ratio,1,0.88 [0.51-1.51],0.633535272234688,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,2,0.96 [0.83-1.12],0.633970942686596,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,2,0.95 [0.75-1.19],0.634310831630169,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Wald ratio,1,0.96 [0.78-1.17],0.657089628687095,cis
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,2,1.04 [0.87-1.26],0.658330121306999,cis
FGF21,Fibroblast growth factor 21,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,2,1.02 [0.93-1.12],0.662584826652903,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,2,1.02 [0.94-1.1],0.662691331576366,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,2,1.07 [0.76-1.52],0.696751899851028,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,2,1.02 [0.92-1.14],0.699933815246937,cis
FGF21,Fibroblast growth factor 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Wald ratio,1,1.24 [0.41-3.77],0.703054940141351,cis
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,2,1.09 [0.68-1.74],0.710262998706061,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,2,1.06 [0.76-1.48],0.714796782261002,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Wald ratio,1,0.93 [0.63-1.38],0.7167634326838,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,2,1.57 [0.13-19.04],0.721852648841886,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Wald ratio,1,1.07 [0.74-1.55],0.726712113675273,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,2,0.96 [0.77-1.2],0.731685541178764,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,2,0.98 [0.85-1.12],0.737604070865522,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,2,0.91 [0.52-1.59],0.738989729932259,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Wald ratio,1,0.95 [0.72-1.26],0.745458360332625,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,2,0.93 [0.62-1.42],0.745473505695406,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,2,1.04 [0.83-1.29],0.746560994078338,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,2,1.11 [0.6-2.06],0.746654100734595,cis
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_B12_DEF,Inverse variance weighted,2,0.89 [0.42-1.88],0.755179725204127,cis
FGF21,Fibroblast growth factor 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,2,1.02 [0.9-1.16],0.781442559490724,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,2,1.03 [0.81-1.31],0.78180566547724,cis
FGF21,Fibroblast growth factor 21,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.93 [0.57-1.52],0.782207769648699,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,2,1.01 [0.93-1.1],0.793225197025408,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1.04 [0.77-1.4],0.804206801198105,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,2,0.95 [0.61-1.49],0.820681102705037,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,2,0.96 [0.67-1.4],0.847345906717865,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Wald ratio,1,0.84 [0.14-4.9],0.847682662628978,cis
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,2,0.95 [0.54-1.69],0.868380153374228,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,0.9 [0.24-3.38],0.872842993730102,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,2,1.05 [0.55-2],0.885648520133098,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,2,0.99 [0.88-1.12],0.902701436836424,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,2,0.98 [0.76-1.28],0.905669670723226,cis
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,2,1.01 [0.82-1.25],0.912201913062659,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Wald ratio,1,1.07 [0.33-3.46],0.912487871874004,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,2,1.02 [0.74-1.4],0.913383475426957,cis
FGF21,Fibroblast growth factor 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,0.97 [0.52-1.8],0.925944233222256,cis
FGF21,Fibroblast growth factor 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,1.03 [0.44-2.42],0.937969593848592,cis
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,2,1.01 [0.7-1.46],0.942943461373122,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_GIBLEEDING,Wald ratio,1,1.02 [0.63-1.63],0.949778692479599,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,1.04 [0.3-3.56],0.952726209503133,cis
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,2,0.96 [0.26-3.59],0.953304358708306,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,1 [0.85-1.19],0.95864612615612,cis
FGF21,Fibroblast growth factor 21,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,2,0.98 [0.36-2.62],0.964398065260388,cis
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,2,1 [0.89-1.13],0.976280709000229,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,2,1 [0.82-1.22],0.978068671929288,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,1.01 [0.54-1.88],0.978707790189873,cis
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,1 [0.87-1.15],0.993562689692972,cis
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,2,1 [0.63-1.58],0.997013516275126,cis
FGF21,Fibroblast growth factor 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,2,2.48 [1.52-4.05],0.000273999506672131,trans
FGF21,Fibroblast growth factor 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,2,2.6 [1.24-5.49],0.0117799315223506,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,2,2.97 [1.22-7.25],0.0165946705488597,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,2,1.22 [1.03-1.45],0.0233605447574972,trans
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,2,1.28 [1.03-1.6],0.0279352639883521,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,2,1.22 [1.02-1.47],0.0335677628103102,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,2,1.85 [1.01-3.37],0.0450820348812089,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,2,0.68 [0.45-1.03],0.0716161557201213,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_CHRONPANC,Inverse variance weighted,2,0.51 [0.24-1.08],0.0791087513491197,trans
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,2,0.72 [0.49-1.04],0.081527222612142,trans
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,1.26 [0.97-1.63],0.0821124835188196,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,2,5.51 [0.77-39.28],0.0888349061791753,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,2,0.68 [0.43-1.06],0.0906193396486268,trans
FGF21,Fibroblast growth factor 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,2,1.25 [0.96-1.62],0.0923759607892212,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,2,1.82 [0.84-3.93],0.126882789904413,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,2,1.91 [0.83-4.39],0.126916767628178,trans
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,2,0.76 [0.53-1.08],0.127724909652885,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,2,1.36 [0.91-2.04],0.135953528145931,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,2,0.86 [0.69-1.07],0.167312027588088,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,2,1.52 [0.84-2.77],0.167778259507433,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,2,1.6 [0.82-3.14],0.170431378866193,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,2,0.79 [0.55-1.12],0.187940680970917,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,2,1.95 [0.72-5.29],0.188111311291868,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,2,0.75 [0.47-1.18],0.208916719486571,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1.79 [0.71-4.54],0.217173395769286,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,2,1.35 [0.83-2.19],0.233639016455854,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,0.56 [0.21-1.51],0.248297932307085,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,2,1.17 [0.89-1.55],0.252847621602676,trans
FGF21,Fibroblast growth factor 21,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,2,1.1 [0.93-1.29],0.256423717984227,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,2,0.14 [0-4.54],0.270186099706553,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,2,0.84 [0.61-1.15],0.274509308459413,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,2,1.19 [0.87-1.63],0.276537123259117,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,2,2.06 [0.54-7.85],0.287689922656038,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,2,1.21 [0.85-1.7],0.289113010545802,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,0.52 [0.15-1.84],0.311733371477778,trans
FGF21,Fibroblast growth factor 21,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.71 [0.35-1.42],0.333420346517421,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_B_DEF,Inverse variance weighted,2,0.38 [0.05-2.92],0.352547335715437,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,2,0.93 [0.79-1.09],0.357265447633846,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,2,0.9 [0.72-1.13],0.359814757673952,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,2,1.19 [0.81-1.75],0.376453556883003,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,2,0.55 [0.14-2.09],0.376574091585307,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,2,1.08 [0.89-1.31],0.454716542364037,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,2,0.81 [0.46-1.42],0.46959862377175,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,2,1.35 [0.6-3.02],0.469937483264831,trans
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,2,1.36 [0.59-3.12],0.474949108852506,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,2,1.15 [0.78-1.7],0.475876430205251,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,F5_ALCOHOLAC,Inverse variance weighted,2,0.85 [0.54-1.35],0.494516086114933,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,2,1.57 [0.42-5.87],0.499778240938961,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_ACUTPANC,Inverse variance weighted,2,0.83 [0.48-1.43],0.500105064590457,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,2,0.75 [0.32-1.74],0.501978661713589,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,2,1.09 [0.85-1.38],0.504026988759916,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,2,0.89 [0.64-1.25],0.510761854362461,trans
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,2,3.69 [0.07-183.23],0.512613681388344,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,2,0.88 [0.57-1.33],0.536582218940411,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,2,1.33 [0.53-3.35],0.550056195285827,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,2,2.32 [0.15-37.19],0.55147709755929,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,2,1.16 [0.71-1.9],0.55290653648458,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,2,0.95 [0.79-1.13],0.553082366987732,trans
FGF21,Fibroblast growth factor 21,Chapter II Neoplasms,CD2_BENIGN_COLORECANI,Inverse variance weighted,2,0.91 [0.67-1.24],0.557136369578723,trans
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,2,1.66 [0.3-9.27],0.562068340331508,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,0.87 [0.54-1.4],0.562408752128441,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,2,0.69 [0.17-2.8],0.600418437467344,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,2,0.82 [0.39-1.73],0.60306380822609,trans
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,2,0.87 [0.52-1.46],0.603760370659722,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,2,0.89 [0.57-1.39],0.607047979770334,trans
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,2,1.05 [0.87-1.27],0.613219693997619,trans
FGF21,Fibroblast growth factor 21,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,2,1.17 [0.62-2.22],0.630885956719861,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_DIVERTIC,Inverse variance weighted,2,0.94 [0.72-1.22],0.635608873054092,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,2,1.52 [0.25-9.37],0.648729269387089,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,2,0.95 [0.75-1.2],0.659025655140406,trans
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,2,1.12 [0.68-1.83],0.659958920922014,trans
FGF21,Fibroblast growth factor 21,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,2,0.76 [0.2-2.81],0.675934647636887,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,2,1.16 [0.56-2.43],0.689268028464627,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,2,0.88 [0.46-1.7],0.703289016748625,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,2,1.1 [0.67-1.81],0.714684171385374,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,0.92 [0.56-1.5],0.734786757446924,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,2,0.87 [0.35-2.14],0.763289371566935,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,2,1.04 [0.81-1.34],0.773815409409946,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,2,1.06 [0.7-1.59],0.790119652972208,trans
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_B12_DEF,Inverse variance weighted,2,1.1 [0.52-2.3],0.806302877396589,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,2,1.1 [0.48-2.53],0.822544083440991,trans
FGF21,Fibroblast growth factor 21,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,2,0.89 [0.3-2.67],0.834299086818382,trans
FGF21,Fibroblast growth factor 21,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,2,0.93 [0.46-1.88],0.842742511426071,trans
FGF21,Fibroblast growth factor 21,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,2,0.93 [0.41-2.12],0.856566842870086,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,2,1.11 [0.3-4.18],0.876461788142936,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,2,0.98 [0.74-1.3],0.880836930871246,trans
FGF21,Fibroblast growth factor 21,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,2,0.98 [0.77-1.25],0.884687375590253,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,2,1.02 [0.76-1.37],0.889780635695273,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_PULMEMB,Inverse variance weighted,2,1.03 [0.66-1.62],0.891920989470779,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,2,0.93 [0.3-2.85],0.896336725481255,trans
FGF21,Fibroblast growth factor 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,2,0.98 [0.64-1.5],0.910331579049637,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,2,1.09 [0.21-5.78],0.916202498695514,trans
FGF21,Fibroblast growth factor 21,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,2,0.95 [0.26-3.44],0.939302483943428,trans
FGF21,Fibroblast growth factor 21,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,2,0.99 [0.57-1.71],0.974426082813791,trans
FGF21,Fibroblast growth factor 21,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,2,1 [0.41-2.41],0.994916412081076,trans
